IL2 and rheumatoid arthritis: Wang et al. demonstrated that patients who received low-dose IL2 therapy in conjunction with conventional therapy had a greater clinical response with a significant decrease in the DAS28 score, 28 tender count, and swollen joint count as compared with RA patients being treated with only conventional therapy [20].